DEZAMIZUMAB
UNII 6U3F28IT58

Substance Identification & Data

This profile provides standardized clinical and technical data for Dezamizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6U3F28IT58.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1662664-56-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6U3F28IT58

CAS Registry Number

1662664-56-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DEZAMIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C153210

National Cancer Institute reference terminology for clinical and research data.

INN ID

10364

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

FG-81

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dezamizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DEZAMIZUMAB

Common Names & Synonyms

ANTI - SAP MAB

DEZAMIZUMAB [INN]

DEZAMIZUMAB [USAN]

DEZAMIZUMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(SERUM AMYLOID P PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL GSK2398852 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GSK2398852 LIGHT CHAIN, DIMER

SYS

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS APCS (AMYLOID P COMPONENT SERUM, SERUM AMYLOID P COMPONENT, SAP, PENTRAXIN-2, PTX2)), HUMANIZED MONOCLONAL ANTIBODY

SYS